Evan Brittain is a Cardiology physician affiliated with Vanderbilt University. OpenAlex indexes 323 publications with 7,387 citations (h-index 43); ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320001
Telephone
615-936-2000Provider last certified this registry record 21 Mar 2022.
Clinical trials
- Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
Sponsor: Vanderbilt University Medical Center
- Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Sponsor: Vanderbilt University Medical Center
- The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Anumana, Inc.Program year20251 payment
- United Therapeutics CorporationProgram year20251 payment
- United Therapeutics CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
12 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Carnitine supplementation in pulmonary arterial hypertension
Vanderbilt University Medical Center
FY2026$874,973R61HL180784 - The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Vanderbilt University Medical Center
FY2026$755,346R33HL158941 - Clinical and Mechanistic Understanding of Right Ventricular Steatosis in Pulmonary Arterial Hypertension
Vanderbilt University Medical Center
FY2026$716,036R01HL155278
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
William Schaffner, MD
Vanderbilt University
Keith Obstein, MD, MPH
Vanderbilt University
Andrew Jallouk, MD, PhD
Vanderbilt University
Salim Yusuf
Vanderbilt University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”